Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.40 |
| ▸ | NPY2R | P49146 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5126806 | 0.87 | MEN1 (0.43) | L3MBTL1MAPTTP53LMNAHTT | |
| SCHEMBL2894937 | 0.83 | KIF11 (0.46) | L3MBTL1MAPTTP53LMNAGPR35 | |
| SCHEMBL23148069 | 0.81 | MAPT (0.62) | L3MBTL1MAPTALDH1A1LMNAGAA | |
| SCHEMBL686791 | 0.80 | RXFP1 (0.48) | L3MBTL1MAPTTP53LMNAGPR35 | |
| SCHEMBL5115340 | 0.76 | KDM4E (0.46) | L3MBTL1MAPTALDH1A1LMNAHTT | |
| SCHEMBL30977683 | 0.75 | TP53 (0.65) | L3MBTL1MAPTALDH1A1TP53LMNA | |
| SCHEMBL4455493 | 0.75 | TP53 (0.65) | L3MBTL1MAPTALDH1A1TP53LMNA | |
| SCHEMBL28197800 | 0.74 | AR (0.56) | L3MBTL1MAPTALDH1A1LMNAHTT | |
| SCHEMBL3736169 | 0.74 | L3MBTL1 (0.73) | L3MBTL1MAPTALDH1A1LMNAHTT | |
| SCHEMBL5118270 | 0.73 | KIF11 (0.44) | L3MBTL1MAPTALDH1A1TP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100305124-A1 | Acylated Aminopyridine and Aminopyridazine Insecticides | BAYER CROPSCIENCE AG (DE) | 2010-12-02 | — | — | US | disclosed |
| EP-2236505-A1 | Acylated aminopyridines and pyridazines as insecticides | Bayer CropScience AG (DE) | 2010-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305124-A1 | Acylated Aminopyridine and Aminopyridazine Insecticides | AAAS, DDT, QDPR | L3MBTL1 1263/4885MAPT 3480/4885ALDH1A1 551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.